Emil Zhang

Associate | They/Them

Overview

Emil Zhang is an associate in the Antitrust and Competition and Health Care groups based in the firm’s Washington, D.C. office. Emil’s practice encompasses complex antitrust litigation, health care antitrust, counseling, and investigations. Collaborating closely with colleagues, Emil delivers client-centric solutions in the dynamic legal landscapes of antitrust and health care.

In their antitrust practice, Emil diligently advocates for clients in actions relating to anticompetitive practices, such as monopolization and reverse payment settlements, under both federal and state antitrust laws. Within the health care sector, Emil represents managed care organizations, insurers, and health care providers in various regulatory and litigation matters.

Emil received their J.D., cum laude, from Georgetown University Law Center in 2025, where they served as notes editor for the American Criminal Law Review and was a member of the Asian Pacific American Law Students Association. During law school, Emil interned for U.S. District Judge Rudolph Contreras in the U.S. District Court for the District of Columbia. They received their B.A. in Economics and Philosophy, Politics, and Law, from Emory University in 2022.

Career & Education

    • U.S. District Court for the District of Columbia
      Judicial Intern, Honorable Rudolph Contreras, 2025
    • Maryland
      Law Clerk, Office of the Attorney General, 2023
    • U.S. District Court for the District of Columbia
      Judicial Intern, Honorable Rudolph Contreras, 2025
    • Maryland
      Law Clerk, Office of the Attorney General, 2023
    • Emory University, B.A., Phi Beta Kappa, Economics and Philosophy, Politics, and Law, 2022
    • Georgetown University Law Center, J.D., cum laude, 2025
    • Emory University, B.A., Phi Beta Kappa, Economics and Philosophy, Politics, and Law, 2022
    • Georgetown University Law Center, J.D., cum laude, 2025
    • District of Columbia
    • District of Columbia

Emil's Insights

Client Alert | 3 min read | 06.24.26

OhioHealth Settlement and White House Report Signal Broader Federal Focus on Restrictive Hospital Contracting

Two significant recent developments illustrate the Trump administration’s increasing focus on policing of hospital contracting practices that limit health plan network design flexibility. On June 16, 2026, the U.S. Department of Justice (DOJ) Antitrust Division and Ohio attorney general filed a proposed consent decree resolving their civil antitrust suit against OhioHealth. (Prior Alert) Two days later, the White House Council of Economic Advisers (CEA) released a memorandum quantifying the potential economic effects of a broader ban on the types of contracting restrictions at issue in the OhioHealth case and the DOJ's parallel suit against NewYork-Presbyterian. This alert updates our prior coverage of the OhioHealth complaint and summarizes both developments....

Emil's Insights

Client Alert | 3 min read | 06.24.26

OhioHealth Settlement and White House Report Signal Broader Federal Focus on Restrictive Hospital Contracting

Two significant recent developments illustrate the Trump administration’s increasing focus on policing of hospital contracting practices that limit health plan network design flexibility. On June 16, 2026, the U.S. Department of Justice (DOJ) Antitrust Division and Ohio attorney general filed a proposed consent decree resolving their civil antitrust suit against OhioHealth. (Prior Alert) Two days later, the White House Council of Economic Advisers (CEA) released a memorandum quantifying the potential economic effects of a broader ban on the types of contracting restrictions at issue in the OhioHealth case and the DOJ's parallel suit against NewYork-Presbyterian. This alert updates our prior coverage of the OhioHealth complaint and summarizes both developments....